MetaVia Reports Positive Results From MAD Part 2 of Phase 1 Study
22 Apr 2025 //
PR NEWSWIRE
MetaVia Reports Positive Data From 4-Week Phase 1 Trial of DA-1726
15 Apr 2025 //
PR NEWSWIRE
MetaVia Reports 2024 Financial Results and Corporate Update
20 Mar 2025 //
PR NEWSWIRE